BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24981249)

  • 1. MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.
    Liu G; Jiang C; Li D; Wang R; Wang W
    Tumour Biol; 2014 Oct; 35(10):9801-6. PubMed ID: 24981249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma.
    Ding H; Zhu Y; Chu T; Wang S
    Tumour Biol; 2014 Oct; 35(10):9987-92. PubMed ID: 25008564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13.
    Ye Y; Zhou X; Li X; Tang Y; Sun Y; Fang J
    Tumour Biol; 2014 Nov; 35(11):10891-6. PubMed ID: 25085584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
    Pei J; Lou Y; Zhong R; Han B
    Tumour Biol; 2014 Jul; 35(7):6673-8. PubMed ID: 24705809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.
    Wang J; Su H; Han X; Xu K
    Tumour Biol; 2014 Nov; 35(11):11005-11. PubMed ID: 25091573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
    Wang F; Xiao W; Sun J; Han D; Zhu Y
    Tumour Biol; 2014 Sep; 35(9):8653-8. PubMed ID: 24867100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer.
    Li J; Wang H; Ke H; Ni S
    Tumour Biol; 2015 Aug; 36(8):5785-90. PubMed ID: 25716201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer.
    Xu L; Hou Y; Tu G; Chen Y; Du YE; Zhang H; Wen S; Tang X; Yin J; Lang L; Sun K; Yang G; Tang X; Liu M
    Cell Death Dis; 2017 Mar; 8(3):e2642. PubMed ID: 28252644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.
    Wang Q; Cai J; Wang J; Xiong C; Zhao J
    Tumour Biol; 2014 Dec; 35(12):12743-8. PubMed ID: 25227664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
    Xie G; Cheng K; Shant J; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation.
    Jiang Y; Sun S; Liu G; Yan B; Niu J
    Tumour Biol; 2015 Feb; 36(2):1129-33. PubMed ID: 25330950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-936 promotes proliferation and invasion of gastric cancer cells by down-regulating FGF2 expression and activating P13K/Akt signaling pathway.
    Chen ZF; Wang J; Yu Y; Wei W
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6707-6715. PubMed ID: 32633361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma
    Li H; Xu X; Liu Y; Li S; Zhang D; Meng X; Lu L; Li Y
    Anticancer Agents Med Chem; 2018; 18(14):2010-2016. PubMed ID: 30501604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR99a modulates MMP7 and MMP13 to regulate invasiveness of Kaposi's sarcoma.
    Zhang J; Wang S; Lu L; Wei G
    Tumour Biol; 2014 Dec; 35(12):12567-73. PubMed ID: 25234715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.
    Zhu S; Belkhiri A; El-Rifai W
    Gastroenterology; 2011 Nov; 141(5):1738-48.e1-2. PubMed ID: 21741919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway.
    Chen Q; Zhang T; Li B; Zhu Z; Ma X; Zhang Y; Li L; Zhu J; Zhang G
    Eur J Med Res; 2024 Jan; 29(1):47. PubMed ID: 38212810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
    Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.